| Cancer, Hypoxia, and Metabolism | Lifetime | 220 | CN 10 | 99.30 |
| Epigenetics and DNA Methylation | Lifetime | 547 | CN 34 | 98.66 |
| MicroRNA in disease regulation | Lifetime | 564 | CN 205 | 98.19 |
| Circular RNAs in diseases | Lifetime | 360 | CN 190 | 97.68 |
| Ferroptosis and cancer prognosis | Lifetime | 466 | CN 245 | 95.14 |
| Ubiquitin and proteasome pathways | Lifetime | 746 | CN 65 | 96.99 |
| Autophagy in Disease and Therapy | Lifetime | 672 | CN 114 | 96.03 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 787 | CN 28 | 95.46 |
| Extracellular vesicles in disease | Lifetime | 996 | CN 356 | 93.84 |
| Cancer Mechanisms and Therapy | Lifetime | 636 | CN 115 | 94.12 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 6 | CN 3 | 99.46 |
| Epigenetics and DNA Methylation | 2021-2025 | 52 | CN 25 | 98.51 |
| RNA modifications and cancer | 2021-2025 | 310 | CN 208 | 97.22 |
| Immune cells in cancer | 2021-2025 | 197 | CN 114 | 95.95 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 141 | CN 37 | 95.40 |
| Extracellular vesicles in disease | 2021-2025 | 401 | CN 242 | 94.26 |
| Ferroptosis and cancer prognosis | 2021-2025 | 614 | CN 519 | 92.57 |
| Ubiquitin and proteasome pathways | 2021-2025 | 333 | CN 147 | 89.93 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 237 | CN 53 | 86.87 |
| Renal cell carcinoma treatment | 2021-2025 | 823 | CN 111 | 89.76 |
| Surfactants and Colloidal Systems | 2021-2025 | 355 | CN 91 | 83.44 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 207 | CN 60 | 81.55 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 326 | CN 63 | 76.53 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 302 | CN 48 | 75.12 |
| Cancer Mechanisms and Therapy | 2021-2025 | 697 | CN 299 | 75.93 |
| Bone Metabolism and Diseases | 2021-2025 | 736 | CN 334 | 73.62 |
| Microtubule and mitosis dynamics | 2021-2025 | 826 | CN 105 | 68.12 |
| Thermodynamic properties of mixtures | 2021-2025 | 441 | CN 52 | 68.51 |
| Signaling Pathways in Disease | 2021-2025 | 735 | CN 287 | 52.82 |
| Caveolin-1 and cellular processes | 2021-2025 | 233 | CN 60 | 52.85 |
| Electrostatics and Colloid Interactions | 2021-2025 | 554 | CN 88 | 46.33 |
| Flavonoids in Medical Research | 2021-2025 | 637 | CN 295 | 33.98 |